HIV-1 patients co-infected with some pathogens are at risk of developing the immune reconstitution inflammatory syndrome (IRIS) when initiating antiretroviral therapy (ART). IRIS is characterized by inflammation leading to the clinical worsening of a treated infection or the unmasking of a previously undiagnosed condition or infection. It is commonly associated with tuberculosis (TB), 8-43% of the HIV-TB co-infected patients prescribed with antitubercular treatment and ART develop TB-IRIS. Although IRIS hasbeen recognized for over 20 years, relatively little was known until recently about its pathogenesis. Despite these advances in understanding IRIS, there remains no immune biomarker for diagnostic or prognostic purposes. Here, we review the risk factors associated with TB-IRIS, the challenges in studying this syndrome, and how T lymphocytes, dysregulated cytokine responses, and innate immunity may contribute to the development of TB-IRIS.Keywords: Drug therapy complications r HIV-1 infection r Immune reconstitution inflammatory syndrome r Tuberculosis
The association between tuberculosis (TB) and TB-human immunodeficiency virus (TB-HIV)Approximately one third of the world's population is considered latently infected by tuberculosis (TB), of which an estimated 5-10% will develop active disease [1]. TB is a leading infectious cause of adult mortality and morbidity worldwide, second only to human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) [2]. In 2011, there were an estimated 8.7 million new cases of TB and 1.4 million deaths [3]. While India Correspondence: Dr. Robert J. Wilkinson e-mail: r.j.wilkinson@imperial.ac.uk and China accounted for almost 40% of the world's TB cases, the African region has the highest incidence and TB-related mortality per capita, attributed mainly to the high prevalence of HIV-1 infection. Among people who are latently infected with TB, HIV-1 is the most important risk factor for developing active TB disease due to progressive immunocompromise. Of the 11 million who were estimated to be dually infected with TB and HIV-1, 79% resided in Africa [3].Several interventions have been implemented to control the TB-HIV-1 syndemic. These include routine HIV testing of TB patients, increased coverage of antiretroviral therapy (ART), intensified TB case finding, and isoniazid preventive therapy for HIV-1-infected persons [3]. The increased accessibility to ART in resource-limited regions has significantly improved the clinical outcome of HIV-1-infected patients and reduced the TB risk by 58-80% [4]. ART can effectively suppress HIV-1 replication, resultingwww.eji-journal.eu 1996 Rachel P. J. Lai et al. Eur. J. Immunol. 2013. 43: 1995 in reduced viral load and increased CD4 + T-cell counts within the first month [5]. The process of CD4 + T-cell recovery begins with the rapid redistribution of the CD45RO + memory population from the lymphoid tissues into the plasma, followed by the slower replenishment of the CD45RA + naïve cells produced in the thymus [5]. This rapid re...